These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37341071)

  • 21. Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell-derived exosome uptake by oral squamous cell carcinoma through macropinocytosis.
    Sasabe E; Tomomura A; Liu H; Sento S; Kitamura N; Yamamoto T
    Cancer Sci; 2022 Feb; 113(2):609-621. PubMed ID: 34874595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
    Chen M; Zhang J
    J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of activated fibroblasts on phenotype modulation, EGFR signalling and cell cycle regulation in OSCC cells.
    Berndt A; Büttner R; Gühne S; Gleinig A; Richter P; Chen Y; Franz M; Liebmann C
    Exp Cell Res; 2014 Apr; 322(2):402-14. PubMed ID: 24394543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-targeting ALK and EGFR parallel signaling in oral squamous cell carcinoma.
    Gonzales CB; De La Chapa JJ; Saikumar P; Singha PK; Dybdal-Hargreaves NF; Chavez J; Horning AM; Parra J; Kirma NB
    Oral Oncol; 2016 Aug; 59():12-19. PubMed ID: 27424178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FBXW7 inhibited cell proliferation and invasion regulated by miR-27a through PI3K/AKT signaling pathway and epithelial-to-mesenchymal transition in oral squamous cell carcinoma.
    Li C; Lin XF; Wang JN; Ren XS
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3701-3709. PubMed ID: 32329846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy and potential mechanisms of pyrotinib in targeting EGFR and HER2 in advanced oral squamous cell carcinoma.
    Zhou L; Le K; Chen Q; Wang H
    BMC Oral Health; 2024 Aug; 24(1):898. PubMed ID: 39107736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P4HA2 promotes proliferation, invasion, and metastasis through regulation of the PI3K/AKT signaling pathway in oral squamous cell carcinoma.
    Chi Z; Wang Q; Wang X; Li D; Tong L; Shi Y; Yang F; Guo Q; Zheng J; Chen Z
    Sci Rep; 2024 Jul; 14(1):15023. PubMed ID: 38951593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deoxypodophyllotoxin Induces ROS-Mediated Apoptosis by Modulating the PI3K/AKT and p38 MAPK-Dependent Signaling in Oral Squamous Cell Carcinoma.
    Seo JH; Yoon G; Park S; Shim JH; Chae JI; Jeon YJ
    J Microbiol Biotechnol; 2022 Sep; 32(9):1103-1109. PubMed ID: 36039387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dacomitinib, an irreversible Pan-ErbB inhibitor significantly abrogates growth in head and neck cancer models that exhibit low response to cetuximab.
    Ather F; Hamidi H; Fejzo MS; Letrent S; Finn RS; Kabbinavar F; Head C; Wong SG
    PLoS One; 2013; 8(2):e56112. PubMed ID: 23405260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of Tyrosine Kinase Receptor 2 in Oral Squamous Cell Carcinoma and the Effect on Cell Proliferation and Migration and Epithelial-Mesenchymal Transition Process].
    Zheng M; Huang Y; Fei W; Shen Y; Nie X; Gao MY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):342-349. PubMed ID: 36949696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppressed mitochondrial respiration via NOX5-mediated redox imbalance contributes to the antitumor activity of anlotinib in oral squamous cell carcinoma.
    Huang Z; Su Q; Li W; Ren H; Huang H; Wang A
    J Genet Genomics; 2021 Jul; 48(7):582-594. PubMed ID: 34373220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exosomal long noncoding RNAs MAGI2-AS3 and CCDC144NL-AS1 in oral squamous cell carcinoma development via the PI3K-AKT-mTOR signaling pathway.
    Li C; Guo H; Xiong J; Feng B; Zhu P; Jiang W; Jiang P; Su X; Huang X
    Pathol Res Pract; 2022 Dec; 240():154219. PubMed ID: 36401978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PDZ-binding kinase inhibitor OTS514 suppresses the proliferation of oral squamous carcinoma cells.
    Kato M; Ota A; Ono T; Karnan S; Hyodo T; Rahman ML; Hasan MN; Onda M; Kondo S; Ito K; Furuhashi A; Hayashi T; Konishi H; Tsuzuki S; Hosokawa Y; Kazaoka Y
    Oral Dis; 2024 Mar; 30(2):223-234. PubMed ID: 36799330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
    Li Z; Yang Z; Passaniti A; Lapidus RG; Liu X; Cullen KJ; Dan HC
    Oncotarget; 2016 May; 7(22):31892-906. PubMed ID: 26895469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of IGF-1 on Proliferation, Angiogenesis, Tumor Stem Cell Populations and Activation of AKT and Hedgehog Pathways in Oral Squamous Cell Carcinoma.
    Ferreira Mendes JM; de Faro Valverde L; Torres Andion Vidal M; Paredes BD; Coelho P; Allahdadi KJ; Coletta RD; Souza BSF; Rocha CAG
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Migration of oral squamous cell carcinoma cells are induced by HGF/c-Met signalling via lamellipodia and filopodia formation.
    Yasui H; Ohnishi Y; Nakajima M; Nozaki M
    Oncol Rep; 2017 Jun; 37(6):3674-3680. PubMed ID: 28440510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of RABL3 suppresses the proliferation and invasion of oral squamous cell carcinoma through inactivating the FAK/AKT pathway.
    Xu Z; Li H; Lin C; Zeng B; Chen Y; Luo Y
    J Bioenerg Biomembr; 2021 Apr; 53(2):203-211. PubMed ID: 33438143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells.
    Zainal NS; Gan CP; Lau BF; Yee PS; Tiong KH; Abdul Rahman ZA; Patel V; Cheong SC
    Phytomedicine; 2018 Jan; 39():33-41. PubMed ID: 29433681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of combining epidermal growth factor receptor inhibitors and cisplatin on proliferation and apoptosis of oral squamous cell carcinoma cells.
    Takaoka S; Iwase M; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M; Shintani S
    Int J Oncol; 2007 Jun; 30(6):1469-76. PubMed ID: 17487368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.